nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
As of 2012, what are the key predictive risk factors for pressure ulcers? Developing French guidelines for clinical practice
|
Michel, J.-M. |
|
2012 |
55 |
7 |
p. 454-465 12 p. |
artikel |
2 |
Editorial Board
|
|
|
2012 |
55 |
7 |
p. i- 1 p. |
artikel |
3 |
Recommandations pour la prise en charge des malades à risque ou porteurs d’escarres
|
Barrois, B. |
|
2012 |
55 |
7 |
p. 452-453 2 p. |
artikel |
4 |
Robert Maigne (1923–2012)
|
Vautravers, P. |
|
2012 |
55 |
7 |
p. 451- 1 p. |
artikel |
5 |
What is the best support surface in prevention and treatment, as of 2012, for a patient at risk and/or suffering from pressure ulcer sore? Developing French guidelines for clinical practice
|
Colin, D. |
|
2012 |
55 |
7 |
p. 466-481 16 p. |
artikel |
6 |
What is the role of TPE in management of patients at risk or with pressure ulcer as of 2012? Towards development of French guidelines for clinical practice
|
Gelis, A. |
|
2012 |
55 |
7 |
p. 517-529 13 p. |
artikel |
7 |
Which medical device and/or which local treatment are to be used, as of 2012, in patients with infected pressure sore? Developing French guidelines for clinical practice
|
Arzt, H. |
|
2012 |
55 |
7 |
p. 498-507 10 p. |
artikel |
8 |
Which medical device and/or which local treatment for prevention in patients with risk factors of pressure sores in 2012. Towards development of French guideline for clinical practice
|
Nicolas, B. |
|
2012 |
55 |
7 |
p. 482-488 7 p. |
artikel |
9 |
Which medical devices and/or local drug should be curatively used, as of 2012, for PU patients? How can granulation and epidermidalization be promoted? Developing French guidelines for clinical practice
|
Nicolas, B. |
|
2012 |
55 |
7 |
p. 489-497 9 p. |
artikel |
10 |
Which medical technology and/or local treatment is most conducive, as of 2012, to pressure sore debridement ? Developing French guidelines for clinical practice
|
Trial, C. |
|
2012 |
55 |
7 |
p. 508-516 9 p. |
artikel |